H Lundbeck A/S H.LUNDBECK ORD SHS/ DK0061804770 /
24/05/2024 18:35:39 | Chg. - | Volume | Bid06:00:03 | Ask06:00:03 | High | Low |
---|---|---|---|---|---|---|
37.10DKK | - | 8,665 Turnover: 286,455.14 |
-Bid Size: - | -Ask Size: - | 37.20 | 36.66 |
GlobeNewswire
05/08
Avalyn Appoints Erin Lavelle, Seasoned Biopharma Finance Executive, to its Board of Directors
GlobeNewswire
01/05
Avalyn Bolsters Leadership Team with the Appointment of Douglas Carlson as Chief Financial Officer a...
GlobeNewswire
29/11/2023
Dianthus Therapeutics Enhances Leadership Team with Appointment of Jeffrey Stavenhagen, Ph.D., as Ch...
GlobeNewswire
28/03/2022
Acumen Pharmaceuticals Reports Financial Results for Full Year Ended December 31, 2021 and Business ...
GlobeNewswire
17/03/2022
Avadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Finan...
GlobeNewswire
07/03/2022
EyePoint Pharmaceuticals Appoints Isabelle Lefebvre as Chief Regulatory Officer
GlobeNewswire
24/02/2022
Dentsply Sirona Announces Appointment of Dr. Dorothea Wenzel as New Board Member
GlobeNewswire
16/02/2022
Mental Health America Releases First-Ever Dashboard With Results of 2.6 Million Mental Health Screen...
GlobeNewswire
14/02/2022
Avadel Pharmaceuticals Appoints Dr. Douglas Williamson as Chief Medical Officer
GlobeNewswire
02/11/2021
Cellectar Appoints Laurence Reilly, M.D., LL.M Interim Chief Medical Officer
GlobeNewswire
13/10/2021
New Analysis Finds St. Louis County, Missouri Had Highest Percentage of Population Screen At-Risk fo...
GlobeNewswire
23/08/2021
Update -- Pharma Two B Appoints Jeffrey Berkowitz as Chairman of its Board of Directors
GlobeNewswire
12/08/2021
Pharma Two B Appoints Jeffrey Berkowitz as Chairman of its Board of Directors